Skip to main content
Premium Trial:

Request an Annual Quote

Coronavirus Test From DiaSorin Molecular Gets FDA Emergency Use Authorization

NEW YORK – An assay from DiaSorin Molecular to detect SARS-CoV-2, the virus that causes COVID-19, has been granted Emergency Use Authorization by the US Food and Drug Administration, the company said on Friday.

The test, called the Simplexa COVID-19 Direct assay, runs on DiaSorin's sample-to-answer Liason MDX real-time PCR instrument. It is intended to qualitatively detect nucleic acid from SARS-CoV-2 in nasopharyngeal swabs from individuals suspected of COVID-19 by their healthcare provider.

The Liason MDX can be used in two configurations. An eight-well direct amplification disc can be used for sample-to-answer testing, while a 96-well Universal Disc is designed for higher-volume testing. The discs require small volumes of sample and the instrument can perform both IVD as well as laboratory-developed tests.

Last week, DiaSorin was awarded $679,000 to further the development of its COVID-19 assay from US Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response's Biomedical Advanced Research and Development Authority, or BARDA, through its EZ-BAA process.

DiaSorin's test was granted EUA on Thursday, as was a test from GenMark. The list of COVID-19 tests with EUA now includes these as well as Roche, Thermo Fisher, Hologic, Quidel, and Abbott.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.